Publications by authors named "Peter Klimko"

Claim this Profile
D
Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma.
Peter G Klimko, Najam A Sharif

Br J Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.
Najam A Sharif, Peter G Klimko

Br J Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotoxicity of 4-(piperazin-1-yl)-8-(trifluoromethyl)pyrido[2,3-e][1,2,4] triazolo[4,3-a]pyrazine, a Potent H4 Receptor Antagonist for the Treatment of Allergy: Evidence of Glyoxal Intermediate Involvement.
Mithat Gunduz, Amanda L Cirello, Peter Klimko, Jennifer L Dumouchel, Upendra A Argikar

Drug Metab Lett· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid: A stable isomer of 15(S)-HETE that retains key vasoconstrictive and antiproliferative activity.
Sandra L Pfister, Peter G Klimko, Raymond E Conrow

Prostaglandins Other Lipid Mediat· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity.
Zixia Feng, Suchismita Mohapatra, Peter G Klimko, Mark R Hellberg, Jesse A May

Bioorg Med Chem Lett· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkey.
Robert D Selliah, Mark R Hellberg, Najam A Sharif, Marsha A McLaughlin, Gary W Williams, Peter G Klimko

Bioorg Med Chem Lett· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
15-Fluoro prostaglandin FP agonists: a new class of topical ocular hypotensives.
Peter Klimko, Mark Hellberg, Marsha McLaughlin, Najam Sharif, Bryon Severns

Bioorg Med Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue.
Mark R Hellberg, Tai-Lee Ke, Karen Haggard, Peter G Klimko, Tom R Dean

J Ocul Pharmacol Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Mark R Hellberg, Marsha A McLaughlin, Naj A Sharif, Louis DeSantis, Tom R Dean, Peter G Klimko

Surv Ophthalmol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.
Mark R Hellberg, Raymond E Conrow, Najam A Sharif, Marsha A McLaughlin, John E Bishop, Peter G Klimko

Bioorg Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis